BioSpace News Archive

Tyme Technologies, Inc., an emerging biotechnology company developing cancer metabolism-based therapies, announced that management will present at the Evercore ISI HealthCONx Conference 2019 on Wednesday, December 4, 2019.

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 150,000 shares of Geron common stock as inducements to two newly-hired employees in connection with commencement of employment with the Company.

Daxor Corporation(NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces new data from The Yale University School of Medicine that was presented on November 16th at the American Heart Association Scientific Sessions in Philadelphia, PA.

Board Realignment Follows SWK’s Acquisition of Enteris BioPharma

A new program will provide Blue Cross Blue Shield of Massachusetts employees with financial coaching and contribute $75 per month toward student loans

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the commercial availability of its Target Selector™ pan-TRK assay for the detection of TRK proteins.

People living with type 2 diabetes can now have on-demand access to specialists and a robust network of endocrinologists directly from their phones

Clover Biopharmaceuticals announced that the first patient was dosed in a Phase I trial of SCB-313, an investigational fully-human TRAIL-Trimer fusion protein, in Australia for the treatment of cancer patients with malignant pleural effusions.

Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small-molecule medicines that directly target RNA, announced today that it has appointed Katrine Bosley as Chairman of its Board of Directors

Exagen Inc. announced today that it entered into an amendment to its loan and security agreement with its primary lender, an affiliate of Innovatus Capital Partners, LLC.